Presentation is loading. Please wait.

Presentation is loading. Please wait.

Choroidal Metastases Responsive to Crizotinib Therapy in a Lung Adenocarcinoma Patient with ALK 2p23 Fusion Identified by ALK Immunohistochemistry Yan.

Similar presentations


Presentation on theme: "Choroidal Metastases Responsive to Crizotinib Therapy in a Lung Adenocarcinoma Patient with ALK 2p23 Fusion Identified by ALK Immunohistochemistry Yan."— Presentation transcript:

1 Choroidal Metastases Responsive to Crizotinib Therapy in a Lung Adenocarcinoma Patient with ALK 2p23 Fusion Identified by ALK Immunohistochemistry Yan Feng, MD, PhD, Arun D. Singh, MD, Christopher Lanigan, MS, Raymond R. Tubbs, DO, Patrick C. Ma, MD Journal of Thoracic Oncology Volume 8, Issue 12, Pages e109-e111 (December 2013) DOI: 10.1097/01.JTO.0000437502.82078.9b Copyright © 2013 International Association for the Study of Lung Cancer Terms and Conditions Terms and Conditions

2 FIGURE 1 Journal of Thoracic Oncology 2013 8, e109-e111DOI: (10.1097/01.JTO.0000437502.82078.9b) Copyright © 2013 International Association for the Study of Lung Cancer Terms and Conditions Terms and Conditions

3 FIGURE 2 Journal of Thoracic Oncology 2013 8, e109-e111DOI: (10.1097/01.JTO.0000437502.82078.9b) Copyright © 2013 International Association for the Study of Lung Cancer Terms and Conditions Terms and Conditions

4 FIGURE 3 Journal of Thoracic Oncology 2013 8, e109-e111DOI: (10.1097/01.JTO.0000437502.82078.9b) Copyright © 2013 International Association for the Study of Lung Cancer Terms and Conditions Terms and Conditions


Download ppt "Choroidal Metastases Responsive to Crizotinib Therapy in a Lung Adenocarcinoma Patient with ALK 2p23 Fusion Identified by ALK Immunohistochemistry Yan."

Similar presentations


Ads by Google